Skip to main content

Videos

April 02, 2020
In this video, part of the "Coping During COVID-19" series, Psych Congress Steering Committee member Rakesh Jain, MD, MPH, shares techniques for maintaining social connectedness in a time of social…
March 19, 2020
Michael Thase, MD, of the University of Pennsylvania, discusses the use of second-generation antipsychotics as an adjunctive therapy in depression.
February 27, 2020
In this video, Christoph U. Correll, MD, of Hofstra/Northwell in New York, discusses the possible clinical applications of the combination of olanzapine and the mu-opioid antagonist samidorphan.
February 27, 2020
In this video, Christoph U. Correll, MD, discusses additional research needed on the combination of olanzapine and the mu-opioid antagonist samidorphan.
February 19, 2020
Michael Thase, MD, provides details on the strategy of combining antidepressants when treating patients with depression.
February 19, 2020
Christoph U. Correll, MD, discusses the results of the ENLIGHTEN‑2 study, which compared weight gain and cardiometabolic side effects in patients taking olanzapine and patients taking olanzapine plus…
February 14, 2020
Psych Congress cochair Charles Raison, MD, hosted a Facebook Live event with Melissa Rosenkranz, PhD, titled "Behind the Science: The Mind-Body Connection."
December 19, 2019
W. Clay Jackson, MD, DipTh, of the University of Tennessee College of Medicine in Memphis, discusses treatment approaches for patients with depression and substance use disorders.
December 13, 2019
Joe Pritchard, CEO of Pinnacle Treatment Centers, discusses how an integrated hub-and-spoke care delivery system allows the organization to be impactful in the communities it enters with regards to…
December 13, 2019
Tani Weiner, JD, shareholder and vice-chair of the behavioral health law group at Polsinelli LLP, and Edith Bauer, Esq., general counsel at Discovery Behavioral Health, discuss issues around…
Back to Top